 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Stanford Spinout Carmenta Bioscience Prepping Validation Study of Preeclampsia Protein Dx
February 01, 2013
Stanford Spinout Carmenta Bioscience Prepping Validation Study of Preeclampsia Protein Dx
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Pronota Validates Pre-Eclampsia Markers; Plans Clinical Study to Support 510(k) Submission
July 13, 2012 / ProteoMonitor - GATC, LifeCodexx Developing Preeclampsia Diagnostic Test
May 12, 2011 / GenomeWeb Daily News - With Two Validation Studies Complete, Pronota Prepping Heart Failure Dx for 2014 Launch
April 26, 2013 / ProteoMonitor - EU Awards $7.6M to Project Aiding Pronota in Validation of Preeclampsia Test
November 9, 2012 / ProteoMonitor - Pronota Raises $4.9M to Support Protein Biomarker Validation Studies; Appoints New CEO, Board Member
January 30, 2012 / ProteoMonitor